ATE380541T1 - Herstellung von vitaminemulsionen und konzentrate davon - Google Patents

Herstellung von vitaminemulsionen und konzentrate davon

Info

Publication number
ATE380541T1
ATE380541T1 AT01967545T AT01967545T ATE380541T1 AT E380541 T1 ATE380541 T1 AT E380541T1 AT 01967545 T AT01967545 T AT 01967545T AT 01967545 T AT01967545 T AT 01967545T AT E380541 T1 ATE380541 T1 AT E380541T1
Authority
AT
Austria
Prior art keywords
vitamin
composition
optionally
drug
water
Prior art date
Application number
AT01967545T
Other languages
English (en)
Inventor
Jimmy Hirschsprung Schlyter
Jan Yngvar Piene
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE380541(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0023067A external-priority patent/GB0023067D0/en
Priority claimed from GBGB0023069.8A external-priority patent/GB0023069D0/en
Priority claimed from GB0023068A external-priority patent/GB0023068D0/en
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Application granted granted Critical
Publication of ATE380541T1 publication Critical patent/ATE380541T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/80—Emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT01967545T 2000-09-20 2001-09-20 Herstellung von vitaminemulsionen und konzentrate davon ATE380541T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0023067A GB0023067D0 (en) 2000-09-20 2000-09-20 Composition
GBGB0023069.8A GB0023069D0 (en) 2000-09-20 2000-09-20 Formulation
GB0023068A GB0023068D0 (en) 2000-09-20 2000-09-20 Method

Publications (1)

Publication Number Publication Date
ATE380541T1 true ATE380541T1 (de) 2007-12-15

Family

ID=27255898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01967545T ATE380541T1 (de) 2000-09-20 2001-09-20 Herstellung von vitaminemulsionen und konzentrate davon

Country Status (17)

Country Link
US (1) US20040043043A1 (de)
EP (1) EP1320356B2 (de)
CN (1) CN1461210A (de)
AT (1) ATE380541T1 (de)
AU (1) AU2001287918A1 (de)
BG (1) BG66237B1 (de)
CZ (1) CZ2003808A3 (de)
DE (1) DE60131862D1 (de)
DK (1) DK1320356T4 (de)
EA (1) EA006141B1 (de)
EE (1) EE200300109A (de)
HU (1) HUP0301250A2 (de)
NO (1) NO340515B1 (de)
PL (1) PL365047A1 (de)
PT (1) PT1320356E (de)
SK (1) SK3232003A3 (de)
WO (1) WO2002024165A2 (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560123B2 (en) * 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
EP1671551A1 (de) * 2001-10-19 2006-06-21 Vita Power Limited Nährengänzungsmittel und Verfahren zur deren Herstellung
PT1487416E (pt) 2002-03-26 2010-01-25 Teva Pharma Micropartículas de fármacos
EP1350435B1 (de) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
EP1526837A1 (de) * 2002-07-24 2005-05-04 Basf Aktiengesellschaft Suspensionen von salzen der ascorbinsäure und ihre verwendung als antioxidantien
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7404489B1 (en) 2003-03-04 2008-07-29 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20050069627A1 (en) * 2003-03-27 2005-03-31 Mysore Nagaraja Rao Ramesh Process for preparation of fructooligosaccharides (FOS)
FR2859603B1 (fr) * 2003-09-11 2005-12-30 Christian Fenioux Utilisation de la neohesperidine dihydrochalcone dans des compositions orales comprenant des vitamines et/ou des mineraux
JP3882125B2 (ja) * 2004-02-19 2007-02-14 三栄源エフ・エフ・アイ株式会社 ニコチン低減剤、及びニコチンの低減方法
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
DE102004043824A1 (de) * 2004-09-10 2006-03-16 Cognis Ip Management Gmbh Emulsionen mit ungesättigten Fettsäuren und deren Estern
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
DE102004046026A1 (de) * 2004-09-21 2006-03-23 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide
US7754264B2 (en) * 2005-01-31 2010-07-13 Nestec S.A. Process for preparing nutritional products
WO2007022345A2 (en) 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
US8153180B2 (en) * 2005-09-06 2012-04-10 Pepsico, Inc. Method and apparatus for making beverages
GB0601498D0 (en) 2006-01-25 2006-03-08 Probio Nutraceuticals As Product
RU2008142388A (ru) * 2006-04-03 2010-05-10 Тева Фармасьютикл Индастриес Лтд. (Il) Микрочастицы лекарственного вещества
CA2656823C (en) * 2006-06-23 2015-02-03 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
AU2014202415B2 (en) * 2006-06-23 2016-02-18 Par Pharmaceutical, Inc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
WO2008074885A2 (en) 2006-12-21 2008-06-26 Novagali Pharma Sa Process for manufacturing ophthalmic oil-in-water emulsions
US20080227892A1 (en) * 2007-03-13 2008-09-18 Van Der Wielen Maarten Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners
AR066076A1 (es) * 2007-04-18 2009-07-22 Sandoz Ag Procedimiento para dosificar sistemas de liberacion de farmacos auto-emulsionantes
MX2010010050A (es) 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
TR200802713A2 (tr) * 2008-04-18 2009-11-23 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. Demir eksikliği tedavisi için demir çinko esaslı bir farmasötik formülasyon
FR2933868B1 (fr) * 2008-07-21 2012-08-17 Oreal Compositions cosmetiques
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
CN101612120B (zh) * 2008-12-16 2011-02-02 海南美大制药有限公司 氟罗沙星冻干乳剂及其生产方法
WO2010075537A1 (en) * 2008-12-23 2010-07-01 Teva Pharmaceutical Industries Ltd. Formulations comprising vitamin d or derivatives thereof
US8663728B2 (en) * 2009-07-21 2014-03-04 Cp Kelco U.S., Inc. Protein stabilizer systems comprising carrageenan for weakly acidic flavored milk drinks
GB2475934A (en) * 2009-12-02 2011-06-08 Fit Bioceuticals Pty Ltd Liquid composition comprising vitamin D
EP2563164B1 (de) 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsionen enthaltend saccharosefettsäureester
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
WO2011153513A2 (en) 2010-06-03 2011-12-08 Latitude Pharma Nanoemulsion composition containing vitamin k
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2768486B1 (de) 2011-10-21 2018-10-03 First Tech International Limited Tocotrienolzusammensetzungen
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (de) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und -therapien
WO2013114003A1 (fr) 2012-01-30 2013-08-08 Laboratoires Urgo Procede de preparation d'un produit sirupeux comprenant des vitamines
CA2863544C (en) 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
US9452135B2 (en) * 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US10335540B2 (en) * 2012-04-17 2019-07-02 Micrel Medical Devices S.A. Pharmaceutical blend infusion thereof and Parkinson's disease monitoring system
RU2496332C1 (ru) * 2012-06-14 2013-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уральский государственный экономический университет" (ФГБОУ ВПО "УрГЭУ") Способ изготовления желейной кондитерской массы
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
NL2010550C2 (en) * 2012-11-30 2014-06-04 Klaas Alouis Riepma An intranasal pharmaceutical composition containing vitamin b12.
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
EA026289B1 (ru) * 2013-12-19 2017-03-31 Зао "Эвалар" Биологически активная добавка к пище в форме коллоида
CA2934007C (en) 2013-12-20 2018-06-12 Pfizer Inc. Pre-moistened wipes for use in treating anal-rectal irritations and disorders
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10314857B2 (en) * 2014-07-02 2019-06-11 Virginia Commonwealth University Compositions and methods for treating carbon monoxide and/or cyanide poisoning
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
EP3187185A4 (de) * 2014-08-29 2018-04-11 Project PM Co., Ltd. Pharmazeutische zusammensetzung aus der kombination einer pyridoxaminverbindung und einer thiaminverbindung
US10117891B2 (en) 2014-09-16 2018-11-06 India Globalization Capital, Inc. Cannabinoid composition for treating pain
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
HUE055224T2 (hu) * 2014-12-23 2021-12-28 Ecosynthetix Inc Biopolimer és izocianát alapú kötõanyagok és kompozit anyagok
US10751300B2 (en) 2015-01-25 2020-08-25 India Globalization Capital, Inc. Composition and method for treating seizure disorders
EP3628398B1 (de) 2015-01-28 2021-08-04 Fona Technologies, Inc. Verfahren zum bereiten eines verkapselten produkts sowie verkapseltes produkt
US10792301B2 (en) 2015-02-13 2020-10-06 The University Of Toledo Therapeutic polysaccharide midi-GAGR and related materials and methods
US11147280B2 (en) 2015-03-12 2021-10-19 Givaudan Sa Emulsions
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
EP3471746A4 (de) * 2016-06-15 2020-02-26 India Globalization Capital, Inc. Verfahren und zusammensetzung zur behandlung von krampfanfällen
US12179379B2 (en) 2017-06-29 2024-12-31 Ecosynthetix Inc. Adhesive with tack and use in wood composite products
KR102781618B1 (ko) * 2017-10-25 2025-03-14 프레제니우스 카비 도이치란트 게엠베하 비경구 적용을 위한 올인원 동결 건조 종합 비타민 에멀젼
US11147761B2 (en) 2018-01-12 2021-10-19 Nicole Akmenkalns Topical supplement composition and method of use
CN114469878A (zh) * 2019-06-12 2022-05-13 北京方同顺医药科技有限公司 一种普罗布考干乳剂组合物及其制备方法和应用
CN111165824A (zh) * 2020-01-21 2020-05-19 北京金康普食品科技有限公司 护眼微量营养素预混料乳剂及其制备方法和应用
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3888684A1 (de) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Zusammensetzung mit verbesserter freiwilliger akzeptanz
CN111544403A (zh) * 2020-05-13 2020-08-18 吉林吉力生物技术研究有限公司 一种犬用阿托伐醌风味片及其制备方法和应用
CN115558659B (zh) * 2022-10-28 2023-05-12 东北农业大学 一种包埋植物乳杆菌乳剂及其制备方法和应用
GB2636420A (en) * 2023-12-13 2025-06-18 Yara Uk Ltd Emulsifiable concentrate comprising vitamin D and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB919193A (en) * 1958-11-12 1963-02-20 Shinshiro Ohtaki A method for producing powder containing oil or fat
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
DK0419885T3 (da) † 1989-08-31 1993-06-14 Paul Resmer Flydende, stabil drikke- og sondeføde indeholdende guarkernemel
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
CH681343A5 (de) * 1990-10-26 1993-03-15 Nestle Sa
WO1992014443A1 (en) * 1991-02-20 1992-09-03 Warner-Lambert Company Microsphere-in-oil emulsion
AU654876B2 (en) * 1991-09-06 1994-11-24 Betatene Limited Carotenoid composition
US5393461A (en) * 1993-10-04 1995-02-28 Rtd Corporation Preparation of stable aqueous emulsions of water-insoluble particles
EP0889721B1 (de) * 1996-03-25 2002-04-17 Bauer, Wulf Heilmittel zur äusserlichen anwendung und verwendung einer wässrigen öl-emulsion für ein derartiges heilmittel
DK0972513T3 (da) * 1997-10-07 2003-07-21 Eisai Co Ltd Fremgangsmåde til fremstilling af emulgeret pulver
DE19756123A1 (de) * 1997-12-17 1999-06-24 Remedia Pharmazeutische Praepa Diätetische oder pharmazeutische Zubereitung
DE19842744B4 (de) * 1998-09-18 2006-12-21 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl und deren Verwendung
GB9906009D0 (en) * 1999-03-16 1999-05-12 Nycomed Pharma As Product
DE19938757A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser

Also Published As

Publication number Publication date
CN1461210A (zh) 2003-12-10
SK3232003A3 (en) 2004-02-03
DE60131862D1 (de) 2008-01-24
EP1320356B2 (de) 2011-06-08
PL365047A1 (en) 2004-12-27
EE200300109A (et) 2005-04-15
AU2001287918A1 (en) 2002-04-02
BG107738A (bg) 2004-01-30
NO340515B1 (no) 2017-05-02
DK1320356T4 (da) 2011-09-12
BG66237B1 (bg) 2012-08-31
DK1320356T3 (da) 2008-01-28
EP1320356A2 (de) 2003-06-25
WO2002024165A3 (en) 2002-12-27
PT1320356E (pt) 2008-01-03
WO2002024165A2 (en) 2002-03-28
EA200300300A1 (ru) 2003-12-25
NO20031249L (no) 2003-05-20
EP1320356B1 (de) 2007-12-12
CZ2003808A3 (cs) 2003-08-13
HUP0301250A2 (hu) 2003-11-28
US20040043043A1 (en) 2004-03-04
EA006141B1 (ru) 2005-10-27
NO20031249D0 (no) 2003-03-18

Similar Documents

Publication Publication Date Title
DE60131862D1 (de) Herstellung von vitaminemulsionen und konzentrate davon
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
NO940319L (no) Framstilling av mikropartikler
BR0005287A (pt) Método para preparação de uma micropartìcula de liberação prolongada e micropartìcula de liberação prolongada assim obtida
IL190497A0 (en) Ophthalmic emulsions containing prostaglandins
HRP20080235T3 (hr) Formulacija vakcine koja sadrži emulziju ulje-u-vodi
DE69940015D1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
NO20025629D0 (no) Formulering
MY137749A (en) New self emulsifying drug delivery system
ATE322250T1 (de) Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen
EP1459801A3 (de) Wasser-in-Öl Emulsionen, insbesondere für Sonnenschutz, und Verfahren zu deren Herstellung
DK1596664T3 (da) Spiselige emulsioner
NO20010491D0 (no) Vann-i-olje-mikroemulsjon som gir basisblandinger for töymyknere kosmetiske attributter
AP2002002384A0 (en) Parenteral cisplatin emulsion
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
FR2806624B1 (fr) Systeme huile silicone/co-solvant concentre en matiere(s) active(s) cosmetique(s) liposoluble(s), emulsion et formulation cosmetiques correspondantes
KR920703047A (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
ATE394468T1 (de) Zweischichtige temporär emulgierbare zusammensetzungen
AR024590A1 (es) Metodo para la preparacion de aglutinados proteicos, aglutinados proteicos, y un producto alimenticio y un preparado farmaceutico que contengan estas.
RU2003115034A (ru) Способ одновременного моделирования хронического панкреатита и гепатита
ATE238772T1 (de) Verfahren zur herstellung von emulgiertem puder
MX9603265A (es) Procedimiento para la preparacion de liquido antiadherente.
TH13324B (th) อิมัลชันชนิดยึดติดกับเมือกชนิดใหม่
TH19571A (th) อิมัลชันชนิดยึดติดกับเมือกชนิดใหม่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1320356

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1320356

Country of ref document: EP